Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Tosat-Bitrián, Carlota
36  Ergebnisse:
Personensuche X
?
1

Casein kinase 1 inhibitor avoids TDP-43 pathology propagati..:

Cuevas, Eva P. ; Martinez-Gonzalez, Loreto ; Gordillo, Clara...
Neurobiology of Disease.  192 (2024)  - p. 106430 , 2024
Link: https://doi.org/10.1016/..
 
?
2

TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid..:

Martinez-Gonzalez, Loreto ; Cuevas, Eva P. ; Tosat-Bitrián, Carlota...
Frontiers in Molecular Neuroscience.  16 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

Nanomedical research and development in Spain: improving th..:

Fernández-Gómez, Paula ; Pérez de la Lastra Aranda, Carmen ; Tosat-Bitrián, Carlota...
Frontiers in Bioengineering and Biotechnology.  11 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
4

Effect of Clinically Used Microtubule Targeting Drugs on Vi..:

Oliva, María Ángela ; Tosat-Bitrián, Carlota ; Barrado-Gil, Lucía...
International Journal of Molecular Sciences.  23 (2022)  7 - p. 3448 , 2022
Link: https://doi.org/10.3390/..
 
?
5

Increasing Brain Permeability of PHA-767491, a Cell Divisio..:

Rojas-Prats, Elisa ; Tosat-Bitrián, Carlota ; Martínez-González, Loreto...
Pharmaceutics.  13 (2021)  2 - p. 180 , 2021
Link: https://doi.org/10.3390/..
 
?
6

CdSe Quantum Dots in Human Models Derived from ALS Patients..:

Tosat-Bitrián, Carlota ; Avis-Bodas, Alicia ; Porras, Gracia...
Nanomaterials.  11 (2021)  3 - p. 671 , 2021
Link: https://doi.org/10.3390/..
 
?
7

CdSe quantum dots evaluation in primary cellular models or ..:

Tosat-Bitrián, Carlota ; Palomo, Valle
Nanomedicine: Nanotechnology, Biology and Medicine.  30 (2020)  - p. 102299 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Specific biosensors in drug discovery for Amyotrophic Later..:

Tosat-Bitrián, Carlota ; Martínez, Ana ; Palomo, Valle
Dianas.  8 (2019)  1 - p. , 2019
Link: https://doi.org/10.37536..
 
?
9

TDP-43: A Key Therapeutic Target beyond Amyotrophic Lateral..:

Palomo, Valle ; Tosat-Bitrian, Carlota ; Nozal, Vanesa...
ACS Chemical Neuroscience.  10 (2019)  3 - p. 1183-1196 , 2019
Link: https://doi.org/10.1021/..
 
?
10

Nanomedical research and development in Spain: improving th..:

Fernández, Paula ; Pérez de la Lastra, C ; Tosat-Bitrian, Carlota...
#PLACEHOLDER_PARENT_METADATA_VALUE#.  , 2023
Link: http://hdl.handle.net/10..
 
?
11

TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid..:

Martínez-González, Loreto ; Cuevas, Eva P ; Tosat-Bitrian, Carlota...
#PLACEHOLDER_PARENT_METADATA_VALUE#.  , 2023
Link: http://hdl.handle.net/10..
 
?
12

TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid..:

Martinez-Gonzalez, Loreto ; Cuevas, Eva P ; Tosat-Bitrián, Carlota...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445132/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
13

Effect of Clinically Used Microtubule Targeting Drugs on Vi..:

Oliva, María A ; Tosat-Bitrian, Carlota ; Barrado-Gil, Lucía...
#PLACEHOLDER_PARENT_METADATA_VALUE#.  , 2022
Link: http://hdl.handle.net/10..
 
?
14

Effect of Clinically Used Microtubule Targeting Drugs on Vi..:

Oliva, María Ángela ; Tosat-Bitrián, Carlota ; Barrado-Gil, Lucía...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998746/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
15

Increasing Brain Permeability of PHA-767491, a Cell Divisio..:

Rojas-Prats, Elisa ; Tosat-Bitrián, Carlota ; Martínez-González, Loreto...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912371/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15